Maternal smoking and CC16 are linked to impaired lung development, lung function decline and emphysema progression, increasing lifelong COPD risk.
Expiratory flow-volume curve concavity predicts future respiratory symptoms but shows lower discriminatory accuracy for COPD incidence than FEV1/FVC.
Gut-lung axis microbiome analysis in stable COPD reveals distinct gut and lung microbiomes associated with airflow limitation, exacerbations and ICS use
BMI genetic factors and COPD are associated with decreased emphysema and increased airway wall thickness across quantitative and visual imaging phenotypes
En este artículo, les presentamos la Conferencia Magistral Manuel Tapia 2018. Dr. Àlvar Agustí García-Navarro. Celebrada en el 51 Congreso Nacional de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), en Palma de Mallorca, del 31 de mayo al 3 de junio de 2018.
Learn why earlier COPD diagnosis and better clinical control during follow-up are essential to reduce exacerbations, improve quality of life and optimise patient outcomes.
Blood biomarkers including CC16, sRAGE and SPD identify pre-COPD lung function trajectories and may improve early COPD risk detection and prevention.
El estudio P4COPD investiga cómo predecir, prevenir y personalizar el manejo de la pre-EPOC en adultos jóvenes mediante medicina de precisión y biomarcadores.
The EXACERBANTES Study explores treatable traits in COPD exacerbations, aiming to improve risk assessment and support personalized clinical management.
GOLD and GLI provide a joint position on spirometry for diagnosing COPD, supporting the fixed FEV1/FVC ratio in the appropriate clinical context.
